Psychotropic medications, mainly phenothiazines, are known to be associated with cardiac insult. The case report presented here describes nearly fatal arrhythmia (sustained supraventricular tachycardia) consequent to phenothiazine treatment. The authors aim to alert psychiatrists to the possible adverse, and even fatal, effects of phenothiazines.
References
1.
ElkayamUFrishmanW.Cardiovascular effects of phenothiazines. American Heart Journal1980; 100:397–401.
2.
KaplanHISadockBJ.Synopsis of psychiatry. 5th ed. Chap 31.1 General principles of psychopharmacology. Baltimore: Williams and Wilkins, 1988:492.
3.
FowlerNOMcCallDChouTCElectrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. American Journal of Cardiology1976; 37:223–30.
4.
KellyHGFayJELavertySG.Thioridazine hydrochloride (Mellaril): its effect on the ECG and a report of two fatalities with ECG abnormalities. Canadian Medical Association Journal1963; 89:546–54.
5.
HollisterLEKosekJC.Sudden death during treatment with phenothiazine derivatives. Journal of the American Medical Association1965; 192:93–6.
6.
MooreMTBookMH: Sudden death in phenothiazine therapy. Psychiatric Quarterly1970; 44:389–402.
7.
GilesTDModlinRK.Death associated with ventricular arrhythmia and thioridazine hydrochloride. Journal of the American Medical Association1968; 205:108–10.
8.
AlexanderCSNinoA.Cardiovascular complications in young patients taking psychotropic drugs. A preliminary report. American Heart Journal1969; 78: 757–69.
9.
ReinertREHermannDG.Unexplained death during chlorpromazine therapy. Journal of Nervous and Mental Disorders1960; 131:434–42.
10.
KriklerDMCurryPVL.Torsade de points, an atypical ventricular tachycardia. British Heart Journal1976; 38:II7–20.
11.
SchoonmakerRWOsteenTGreenfieldJC.Thioridazine (Mellaril) induced ventricular tachycardia controlled with artificial pacemaker. Annals of Internal Medicine1966; 65:1076–8.
12.
LeestmaJEKoenigKL.Sudden death and phenothiazines. Archives of General Psychiatry1968; 18:137–48.
DietzmanRHLilleheiRC.The treatment of cardiogenic shock. Part IV. The use of phenoxybenzamine and chlorpromazine. American Heart Journal1968; 75: 136–8.
15.
GreinerACNicolsonGA.Pigment deposition in viscera associated with prolonged chlorpromazine therapy. Canadian Medical Association Journal1964; 91:627–35.
16.
RichardsonHLGraupnerKIRichardsonME.Intramyocardial lesions in patients dying suddenly and unexpectedly. Journal of the American Medical Association1966; 195:114–20.
17.
MehtonenOPArankoKMalkonenLVapaataloH.A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatrica Scandinavica1991; 1:58–64.
18.
FlugelmanMYTalAPollackSPsychotropic drugs and long QT syndromes: case reports. Journal of Clinical Psychiatry1985; 46:290–291.
19.
McCreadieRGToddNLivingstonMA double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia. Acta Psychiatrica Scandinavica1988; 78:49–56.
